Skip to main
HSIC
HSIC logo

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 25 analyst ratings
Hold
Strong Buy 16%
Buy 24%
Hold 52%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. reported a robust performance in its dental segment, achieving a revenue growth of 6.2% and an impressive increase in dental consumables revenue by 4.8%. The company's global technology segment also contributed to growth, generating $160 million and experiencing a 2.4% rise in revenue. Furthermore, the firm's outlook for adjusted EBITDA growth in mid-single digits and a forecasted increase in non-GAAP EPS indicates a positive trend leading up to 2025, reflecting an overall confidence in the company’s financial trajectory.

Bears say

Henry Schein Inc. has experienced a disappointing fourth quarter, with revenue of $3.19 billion reflecting a 5.8% increase but falling significantly short of the company's original expectation of $3.35 billion. The gross margin for the quarter was 31.1%, underperforming against the expected 31.6%, contributing to an overall earnings shortfall attributed to a weak top-line performance. Furthermore, management indicated short-term headwinds related to a shift to a SaaS model and unfavorable seasonal factors, such as the timing of Christmas and flu season, exacerbated the company's challenges during the quarter.

Henry Schein (HSIC) has been analyzed by 25 analysts, with a consensus rating of Hold. 16% of analysts recommend a Strong Buy, 24% recommend Buy, 52% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 25 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.